psychopharmacologic management. Psychiatr Med 1991; 9: 313-329.
48. Haller D.L., Miles D.R. Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of live // AIDS Behav. –2003. –Vol. 7. – P. 101–108.
49. Halman MH,Worth JL, Sanders KM, et al. Anticonvulsant use in the treatment of manic syndrome in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 1993; 5: 430-434.
50. Hamers F. and Downs A. HIV in central and eastern Europe. The Lancet. – 2003. – Vol. 361. – Р. 1035-44, 22March.
51. Horwath E, Kramer M, Cournos F, et al. Clinical presentations of AIDS and HIV infection in state psychiatric facilities. Hosp Comm Psychiatry 1989; 40: 502-514.
52. Jacobsberg LB, Perry S. Medical management of AIDS patients: psychiatric disturbances. Med Clin North Am 1992; 76: 99-106.
53. Janicak PG. Psychopharmacotherapy in the HIV-infected patient. Psychiatric Ann 1995; 25 (10): 609-613.
54. Jobe ТН. Neuropsychiatry of HIV disease. In: Flaherty J, Davis JM, Janicak PG, eds. Psychiatry: diagnosis and therapy. New York: Appleton and Lange, 1993.
55. Justice A.C., McGinnis K.A., Atkinson J.H. et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study // AIDS. – 2004. – Vol. 18, Suppl.1. – P. 49–59.
56. Kalichman S (1995). Understanding AIDS: A guide for mental health professionals. American Psychological Association. Washington DC, USA.
57. Kalichman S.C., Heckman T., Kochman A., Sikkema K., Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS // Psychiatr. Serv. – 2000. – Vol. 51. – P. 903–907.
58. Kalichman SC, KellkyJA, Johnson J, et al. Factors associated with risk for human immunodefciency versus (HIV) infection among chronically mentally ill adults. Am J Psychiatry 1993; 151:121-127.
59. King M.B. AIDS, HIV and Mental Health. Cambridge: Cambridge niversity Press, 1993.
60. King M.B. Psychological status of 192 out-patients with HIV infection and AIDS // Br. J. Psychiatry. – 1989. – Vol. 154. – P. 237–242.
61. Lishman’s organic psychiatry: a textbook of neuropsychiatry /A. David et al. (Eds.). 4th Edition. Part 2. – 2009. – Ch. 7. – P. 397–472.
62. Low-Beer S., Clan K., Hogg R.S. et al. Depressive symptoms decline among persons on HIV protease inhibitors // J. Acquired Immune Defc. Syndrome. – 2000. – Vol. 23. – P. 295– 301.
63. Lyketsos C.G., Hanson A.L., Fishman M. et al. Screening for psychiatric disorders in an HIV medical clinic: the importance of a psychiatric presence // Int. J. Psychiatry. Med. – 1994. – P. 103– 113.
64. Maj M, Janssen R, Starace F, et al. WHO neuropsychiatry AIDS study, cross-sectional phase 1. Arch Gen Psychiatry 1994; 51: 39-49.
65. Marzuk P.M. Suicidal behavior and HIV illness // Int. Rev. Psychiatry. 1991. – Vol. 3. – P. 365–371.
66. Marzuk P.M., Tierney H., Tardif K. et al. Increased risk of suicide in persons with AIDS // J. Am. Med. Association. – 1988. – Vol. 259. – P. 1333–1337.
67. Maschke M., Kastrup O., Esser S. et al. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) // J. Neurology, Neurosurgery and Psychiatry. – 2000. – Vol. 69. – P. 376–380.
68. Menza MA, Murray GB, Holmes VF, et al. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280.
69. Navia B.A., Lee P.L., Chang L. et al. Metabolite changes in the basal ganglia provide a signature for the AIDS dementia complex: a multicenter proton magnetic resonance study // Neurology. – 1999. – Vol. 52. – P. (S2): A253.
70. Ofah C.E., Turnbull I.W. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients // Clin. Radiol. – 2006. – Vol. 61. – P. 393–401.
71. Ostrow D, Grant I, Atkinson H. Assessment and management of AIDS patients with neuropsy-chiatric disturbances. J Clin Psychiatry 1988; 49 (Suppl): 14-22.
72. Patrick D., Tyndall M., Cornelisse P. et al. Incidence of hepatitis C virus among drug users duringan outbreak of HIV infection. // Canadian Medical Association Journal. – 2001. – Vol. 165. – Р. 889–895.
73. Pence B.W., Miller W.C., Whetten K. et al. Mental disorders common among HIV-infected patients // J. Acquired Immune Defcit Syndrome. – 2006. – Vol. 42. – P. 298–306.
74. Perkins D.O., Stern R.A., Golden R.N. et al. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic // Am. J. Psychiatry. – 1994. – Vol. 151. – P. 223–236.
75. Preskorn S, Janicak PG, Davis JM, Ayd F Jr. Advances in the psychopharmacotherapy of depressive disorders. In: Janicak PG, ed.
76. Principles and practice of psychopharmacotherapy. Update, Vol 1 (3). Baltimore: Williams & Wilkins, 1995.
77. Regier D., Farmer M., Rae D. et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association. – 1990. – Vol. 26 (19). – Р. 2511-2518.
78. REPSSI (2004). About REPSSI: State of the initiative, 2003. Regional Psychosocial Support Initiative. http://www.repssi.org/ initiativestate.htm
79. Sejvar J.J. The evolving epidemiology of viral encephalitis // Curr. Opinion Neurol. – 2006. – Vol. 19. – P. 350–357.
80. Sewell D. Schizophrenia and HIV // Schizophr. Bull. – 1996. – Vol. 22. – P. 465–473.
81. Shader R.I., Kennedy J.S. Biological treatments / H.I.Kaplan, B.J.Sadock (Eds.). Comprehensive Textbook of Psychiatry. Baltimore: Williams and Wilkins, 1989. – Vol. 2. – P. 2037– 2049.
82. Singh A, Catalan J: Risperidone in HIV-related manic psvchosis [Letter], Lancet 1994; 344:1029 -1030.
83. Sitdis J.J. et al. Стадии СПИД-дементного комплекса, 1990.
84. Thomas C.S., Szabadi E. Paranoid psychosis as the frst presentation of a fulminating lethal case of AIDS // Br. J. Psychiatry. – 1987. – Vol. 151. – P. 693–695.
85. Treisman G.J., Angelino A.F., Hutton H.E. Psychiatric issues in the management of patients with HIV infection // J. Am. Med. Association. – 2001. – Vol. 286. – P. 2857– 2864.
86. Treisman G.J., Fishman M., Lyketsos C.G., McHugh P.R. Evaluation and treatment of psychiatric disorders associated with HIV infection // HIV, AIDS and the Brain, Ch.13. Association for Research in Nervous and Mental Disease, Vol.72 / R.W. Price, S.W. Perry (Eds.). New York: Raven Pres, 1994.
87. Uldall KK, Koutsky LA, Bradshaw DH, et al. Psychiatric comorbidity and length of stay in hospitalized AIDS patients. Am J Psychiatry 1994; 151: 1475-1478.
88. UNAIDS (2002). Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
89. UNAIDS (2004a). Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
90. UNAIDS (2004b). The changing HIV/AIDS epidemic in Europe and Central Asia.CP 102, UNAIDS,Geneva, Switzerland. Free download from www.unaids.org/en/Regions_Countries/Regions/EasternEuropeAndCentralAsia/asp
91. UNAIDS (2005). Report on the global AIDS epidemic. UNAIDS, Geneva, Switzerland.
92. Wang F., So Y., Vittinghof E. et al. Incidence, proportion and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis and cryptococcal meningitis // J. Acquired Immune Defciency Syndrome Human Retrovirology. – 1995. – Vol. 8. – P. 75–82.
93. WHO (2001). Project Atlas: Mental health resources around the world. WHO, Geneva, Switzerland. www.who.int/mental_health/ evidence/en
94. Yarchoan R, Brouwers P Spitzer AR, et al. Response ofhuman-immunodefciency associated neurological disease to 3’-azido-3’-deoxythymi-dine. Lancet 1987; 1: 132-135.
95. Yeung H., Krentz H.B., Gill M.J., Power C. Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care // AIDS. – 2006. – Vol. 20. – P. 2005–2009.
96. Yiannoutsos C.T., Ernst T., Chang L. et al. Regional patterns of brain metabolites in AIDS dementia complex // Neuroimage. – 2004. – Vol. 23. – P. 928–935.
Сведения об авторах- составителях пособия
Сыропятов Олег Геннадьевич – профессор кафедры военной терапии Украинской военно-медицинской академии МО Украины, доктор медицинских наук, профессор, академик Крымской АН. Врач-психиатр высшей категории.
Дзеружинская Наталия Александровна – доцент кафедры психиатрии и наркологии Национального медицинского университета им. А.А. Богомольца (Киев), доктор медицинских наук, старший научный сотрудник. Врач-психиатр высшей категории.
Солдаткин Виктор Александрович – заведующий кафедрой психиатрии и наркологии ФПК и ППС Ростовского государственного медицинского университета. Руководитель центра психологической поддержки РостГМУ, доктор медицинских наук, доцент. Врач-психиатр высшей категории. Член Правления Российского общества психиатров.
Крылов Владимир Иванович – профессор кафедры психиатрии и наркологии с курсом медицинской психологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. Павлова, доктор медицинских наук, профессор.
Перехов Алексей Яковлевич – доцент кафедры психиатрии и наркологии ФПК и ППС Ростовского государственного медицинского университета. Кандидат медицинских наук, доцент. Врач-психиатр высшей категории. Вице-президент Независимой психиатрической ассоциации России.
